Molecular dissection of BMP signaling pathways in control and fibrodysplasia ossificans progressiva lymphoblastoid cells.

被引：0
|
作者：
Fiori, JL [1 ]
Billings, PC [1 ]
Kaplan, FS [1 ]
Shore, EM [1 ]
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [41] Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva
    Ravazzolo, Roberto
    Cappato, Serena
    Bocciardi, Renata
    BONE, 2018, 109 : 187 - 191
  • [42] Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva
    Hino, Kyosuke
    Horigome, Kazuhiko
    Nishio, Megumi
    Komura, Shingo
    Nagata, Sanae
    Zhao, Chengzhu
    Jin, Yonghui
    Kawakami, Koichi
    Yamada, Yasuhiro
    Ohta, Akira
    Toguchida, Junya
    Ikeya, Makoto
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (09): : 3345 - 3358
  • [43] Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype
    Kan, LX
    Hu, M
    Gomes, WA
    Kessler, JA
    AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04): : 1107 - 1115
  • [44] New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva
    Matsumoto, Yoshihisa
    Ikeya, Makoto
    Hino, Kyosuke
    Horigome, Kazuhiko
    Fukuta, Makoto
    Watanabe, Makoto
    Nagata, Sanae
    Yamamoto, Takuya
    Otsuka, Takanobu
    Toguchida, Junya
    STEM CELLS, 2015, 33 (06) : 1730 - 1742
  • [45] Mutations in the BMP type I receptor ACVR1 in patients with fibrodysplasia ossificans progressiva (FOP).
    Shore, E. M.
    Xu, M.
    Connor, J. M.
    Kaplan, F. S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S75 - S75
  • [46] Early fibrodysplasia ossificans progressiva-like lesion formation in nude mice following implantation of lymphoblastoid cells from FOP patients
    Billings P.C.
    Wu Y.
    Caron R.
    Serrano De La Peña L.
    Young B.
    Pacifici M.
    Glaser D.L.
    Shore E.M.
    Kaplan F.S.
    Clinical Reviews in Bone and Mineral Metabolism, 2005, 3 (3-4): : 225 - 228
  • [47] Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva
    Barruet, Emilie
    Hsiao, Edward C.
    BONE, 2018, 109 : 162 - 167
  • [48] Altered GS domain mechanics by the fibrodysplasia ossificans progressiva mutant ACVR1 receptor reduces regulatory constraints on BMP pathway signaling
    Allen, Robyn S.
    Jones, William D.
    Warder, Bailey N.
    Hale, Maya
    Shore, Eileen M.
    Mullins, Mary C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 291 - 291
  • [49] Periosteal Pdgfra-lineage cells contribute to heterotopic ossification in Fibrodysplasia Ossificans Progressiva
    Rivera, Loreilys Mejias
    Mourkioti, Foteini
    Shore, Eileen M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 10 - 10
  • [50] ELEVATED PROSTAGLANDIN PRODUCTION IN CULTURED-CELLS FROM A PATIENT WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
    MAXWELL, WA
    HALUSHKA, PV
    MILLER, RL
    SPICER, SS
    WESTPHAL, MC
    PENNY, LD
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1978, 15 (01) : 123 - 129
12345